Anti-cancer drug, Genexol sold at over 10 billion won.

Genexol (paclitaxel), an anti-cancer drug, was developed by Samyang and distributed by CJ, now reaching its sales to 10 billion won at the early of Dec., which may achieve 11 billion won up the end of this year.

Unlike cardiovascular and other drugs, most of anti-cancer drug markets have been predominated by imported products such as Gleevec (Novartis) and Taxol (BMS). Given such situation...